Ads
related to: merkel's cancer
Search results
...-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell...
Morningstar· 15 hours ago(Nasdaq:KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced positive results from the primary analysis ...
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 9 hours ago(NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its leading cancer vaccine...
4 of the most common head and neck skin cancers, and how to identify them
ClickOnDetroit· 3 days agoGetting a sun-kissed tan might look great, but it ultimately causes damage that can lead to skin ...
Onramp Hires Mark Connors as Managing Director, Head of Global Macro Strategy to Accelerate Bitcoin...
Digital Journal· 14 hours agoReceives Notice of Allowance for Additional Patent in Portfolio of Wildfire Mitigation Technologies More from Digital Journal Let’s waltz! Vienna ball season back in full ...
Shedding light on skin cancer awareness: How lasers are being used to prevent sun damage
WTSP-TV Tampa· 6 days agoMay is Skin Cancer Awareness Month. According to the American Academy of Dermatology, skin cancer is...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days agoNet product revenues of Iclusig were almost $30.3 million...Zacks Consensus Estimate of $22.1...
Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com
Investing.com· 6 days agoPhio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company specializing in gene silencing...
Drs. Bridget Bryer and Lynn Dengel: When is Mohs surgery the best skin cancer treatment option?
The Daily Progress· 6 days agoThis is a specialized surgery results in very high cure rates, but it's not for everyone.
...Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical...
Digital Journal· 7 days agoThere have been no dose-limiting toxicities, or clinically relevant treatment...development of PH-762," said Mary Spellman MD, Phio's acting Chief Medical Officer. "We are ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day ago“As our company is now increasingly focused on our lead asset petosemtamab and plan to initiate phase 3 trials in head and neck cancer later this year, we aim to advance clinical ...
